NSEI:EMAMILTD - アナリストの将来予測と過去の財務データ ( )INR Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
3/31/2027	46,921	10,758	11,112	N/A	19
3/31/2026	43,143	9,466	9,575	N/A	26
3/31/2025	39,352	8,339	8,369	N/A	26
6/30/2024	36,585	7,385	N/A	N/A	N/A
3/31/2024	35,781	7,235	7,384	7,790	N/A
12/31/2023	35,228	7,191	N/A	N/A	N/A
9/30/2023	35,092	6,978	8,133	8,461	N/A
6/30/2023	34,581	7,035	N/A	N/A	N/A
3/31/2023	34,057	6,396	7,084	7,489	N/A
12/31/2022	33,428	8,511	N/A	N/A	N/A
9/30/2022	33,311	8,339	1,423	6,281	N/A
6/30/2022	33,094	8,350	N/A	N/A	N/A
3/31/2022	31,872	8,390	1,603	6,439	N/A
12/31/2021	31,524	5,707	N/A	N/A	N/A
9/30/2021	31,142	5,597	7,300	7,710	N/A
6/30/2021	30,601	4,929	N/A	N/A	N/A
3/31/2021	28,805	4,547	8,878	9,215	N/A
12/31/2020	26,825	3,903	N/A	N/A	N/A
9/30/2020	25,615	3,257	6,250	6,740	N/A
6/30/2020	24,876	3,033	N/A	N/A	N/A
3/31/2020	26,549	3,029	3,717	5,307	N/A
12/31/2019	27,609	3,357	N/A	N/A	N/A
9/30/2019	27,593	3,292	4,484	6,411	N/A
6/30/2019	27,272	3,158	N/A	N/A	N/A
3/31/2019	26,946	3,032	4,145	5,537	N/A
12/31/2018	26,703	3,073	N/A	N/A	N/A
9/30/2018	26,162	3,168	N/A	N/A	N/A
6/30/2018	26,161	3,328	N/A	N/A	N/A
3/31/2018	25,305	3,071	N/A	5,878	N/A
12/31/2017	24,875	3,302	N/A	N/A	N/A
9/30/2017	24,446	3,174	N/A	N/A	N/A
6/30/2017	23,887	2,848	N/A	N/A	N/A
3/31/2017	24,882	3,404	N/A	7,296	N/A
12/31/2016	27,855	3,347	N/A	N/A	N/A
9/30/2016	27,849	3,347	N/A	N/A	N/A
6/30/2016	27,310	3,291	N/A	N/A	N/A
3/31/2016	23,583	3,635	N/A	5,616	N/A
12/31/2015	25,067	4,215	N/A	N/A	N/A
9/30/2015	24,104	4,711	N/A	N/A	N/A
6/30/2015	23,254	5,025	N/A	N/A	N/A
3/31/2015	22,172	4,856	N/A	5,340	N/A
12/31/2014	21,093	4,584	N/A	N/A	N/A
9/30/2014	20,017	4,254	N/A	N/A	N/A
6/30/2014	19,189	4,126	N/A	N/A	N/A
3/31/2014	18,208	4,025	N/A	4,282	N/A
12/31/2013	18,316	3,853	N/A	N/A	N/A

アナリストによる今後の成長予測

収入対貯蓄率: EMAMILTDの予測収益成長率 (年間11.6% ) は貯蓄率 ( 6.7% ) を上回っています。

収益対市場: EMAMILTDの収益 ( 11.6% ) Indian市場 ( 16% ) よりも低い成長が予測されています。

高成長収益: EMAMILTDの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: EMAMILTDの収益 ( 8.4% ) Indian市場 ( 9.6% ) よりも低い成長が予測されています。

高い収益成長: EMAMILTDの収益 ( 8.4% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: EMAMILTDの自己資本利益率は、3年後には高くなると予測されています ( 29.2 %)

Emami 将来の成長

Future 基準チェック /26

主要情報

今後の成長に関する最新情報

Price target increased by 8.4% to ₹778

Price target increased by 8.2% to ₹613

Price target increased by 7.6% to ₹517

Price target decreased by 7.3% to ₹510

Price target increased to ₹619

Emami Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Recent updates

Price target increased by 8.4% to ₹778

Emami Limited, Annual General Meeting, Aug 27, 2024

First quarter 2025 earnings: EPS misses analyst expectations

What Is Emami Limited's (NSE:EMAMILTD) Share Price Doing?

Emami Limited to Report Q1, 2025 Results on Aug 01, 2024

Is Emami (NSE:EMAMILTD) Using Too Much Debt?

Emami Limited's (NSE:EMAMILTD) 35% Price Boost Is Out Of Tune With Earnings

Investor sentiment improves as stock rises 33%

Price target increased by 8.2% to ₹613

Emami (NSE:EMAMILTD) Ticks All The Boxes When It Comes To Earnings Growth

Full year 2024 earnings released: EPS: ₹16.55 (vs ₹14.50 in FY 2023)

Emami Limited (BSE:531162) signed a share purchase agreement to acquire 4.64% stake in Brillare Science Pvt. Ltd. from founder and other shareholders of Brillare Science Pvt. Ltd.

Is There Now An Opportunity In Emami Limited (NSE:EMAMILTD)?

Dividend of ₹4.00 announced

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Emami Limited Approves Second Interim Dividend for the Financial Year 2023-24

Investor sentiment improves as stock rises 16%

Emami (NSE:EMAMILTD) Seems To Use Debt Rather Sparingly

Emami (NSE:EMAMILTD) Has Affirmed Its Dividend Of ₹4.00

Emami Limited Declares Interim Dividend for the Financial Year 2023-24

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Emami Limited (BSE:531162) completed the acquisition of 26% stake in Axiom Ayurveda Private Limited

Emami Limited (BSE:531162) entered into definitive agreement to acquire 26% stake in Axiom Ayurveda Private Limited.

Emami Limited Announces Change in Management

Manipal Health Enterprises Pvt Ltd acquired 84% stake in AMRI Hospitals Ltd. from Emami Limited (BSE:531162).

Manipal Health Enterprises Pvt Ltd acquired 84% stake in AMRI Hospitals Ltd. from Emami Limited (BSE:531162).

Emami Limited Announces Changes to the Senior Management Personnel

Insider recently bought ₹1.0m worth of stock

Emami May Seal AMRI Sale to Manipal Group This Month

Price target increased by 7.6% to ₹517

Emami Limited Announces Cessation of Mr. Vinod Rao, President-CCD, Personnel of Senior Management Effective from the Closing Hours of July 31, 2023

Is Now The Time To Look At Buying Emami Limited (NSE:EMAMILTD)?

Full year 2023 earnings: EPS misses analyst expectations

Emami Limited to Report Q4, 2024 Results on May 30, 2024

Emami Limited Proposes Two Interim Dividends for the Financial Year 2022-23

Emami Limited, Annual General Meeting, Aug 23, 2023

Does Emami (NSE:EMAMILTD) Have A Healthy Balance Sheet?

Emami Limited to Report Q1, 2024 Results on Aug 07, 2023

Emami Limited Approves Executive Changes

Full year 2023 earnings: EPS misses analyst expectations

What Is Emami Limited's (NSE:EMAMILTD) Share Price Doing?

These 4 Measures Indicate That Emami (NSE:EMAMILTD) Is Using Debt Reasonably Well

Emami (NSE:EMAMILTD) Is Due To Pay A Dividend Of ₹4.00

Price target decreased by 7.3% to ₹510

Third quarter 2023 earnings: EPS exceeds analyst expectations

Emami Limited Declares Second Interim Dividend for the Financial Year 2022-23

Here's Why We Think Emami (NSE:EMAMILTD) Might Deserve Your Attention Today

Emami Limited to Report Q3, 2023 Results on Feb 03, 2023

Max Healthcare Reportedly Eyeing AMRI Hospitals

Emami's (NSE:EMAMILTD) Dividend Will Be ₹4.00

Second quarter 2023 earnings: EPS exceeds analyst expectations

Emami (NSE:EMAMILTD) Seems To Use Debt Quite Sensibly

Second quarter 2023 earnings: EPS exceeds analyst expectations

Emami Limited Declares Interim Dividend for the Financial Year 2022-23

With EPS Growth And More, Emami (NSE:EMAMILTD) Makes An Interesting Case

Emami Limited to Report Q2, 2023 Results on Nov 11, 2022

Is Now An Opportune Moment To Examine Emami Limited (NSE:EMAMILTD)?

Emami Limited, Annual General Meeting, Sep 09, 2022

First quarter 2023 earnings released: EPS: ₹1.67 (vs ₹1.75 in 1Q 2022)

We Ran A Stock Scan For Earnings Growth And Emami (NSE:EMAMILTD) Passed With Ease

Emami Limited (BSE:531162) acquired 30% stake in Cannis Lupus Services India Private Limited.

Emami Limited to Report Q1, 2023 Results on Jul 29, 2022

Emami (NSE:EMAMILTD) Could Easily Take On More Debt

Full year 2022 earnings: EPS exceeds analyst expectations

Is Now The Time To Put Emami (NSE:EMAMILTD) On Your Watchlist?

Emami Limited Announces Executive Changes

Is Emami (NSE:EMAMILTD) Using Too Much Debt?

Emami Limited (BSE:531162) acquired 19% equity stake in Tru Native F&B Private Limited.

Emami (NSE:EMAMILTD) Has Affirmed Its Dividend Of ₹4.00